相关实验视频

Updated: Feb 15, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

异构糖氨酸受体中域合的结构基础由非典型的全性激素激剂揭示出来

Eric Gibbs¹, Bjarne Feddersen², Kayla J Kindig¹

¹Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106-4970, USA.

Science advances

|February 13, 2026

概括

对甘氨酸受体 (GlyR) 关口的结构性洞察力揭示了艾弗梅克如何通过不同的跨膜和细胞外域机制激活这些通道,即使有施尼存在.

科学领域:

神经科学是一个神经科学.
结构生物学结构生物学
生物化学生物化学

背景情况:

甘氨酸受体 (GlyRs) 是一种氨酸联离子通道 (pLGIC),对感觉和运动功能至关重要.
虽然GlyR的功能状态已知,但这些状态之间的过渡的结构基础仍然不清楚.

研究的目的:

阐明GlyR关和全调节背后的结构机制.
研究跨膜域 (TMD) 激动剂和细胞外域 (ECD) 抗剂之间的相互作用.

主要方法:

低温电子显微镜 (cryo-EM) 用于确定用gephyrin E-domain的GlyRα1β结构.
电生理学评估GlyR激活在ivermectin和strichnine的存在下.
分子动力学 (MD) 模拟来分析连接体相互作用和域动力学.

主要成果:

结构揭示了中间的GlyR状态与无敏的TMD和封闭状态和无敏状态之间的ECD形态.
即使在尼因被结合时,也会激活GlyR,这表明复杂的全调制.
模拟MD显示ivermectin影响斯特里尼尼动态,支持一个协调的TMD激活机制.

结论:

艾弗梅克丁激活GlyR涉及到一个协调的,对称的TMD机制.
电脑电磁盘的度调制是分级的,并且在空间上是异质的.
这些发现为GlyR关口和PLGIC全调节的原理提供了新的见解.

更多相关视频

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Published on: November 30, 2018

相关概念视频

G-protein Coupled Receptors

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Drug-Receptor Interaction: Agonist

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

Conservation of Protein Domains Over Different Proteins

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...